Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: FABRICO TECHNOLOGY, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-03-12 to 2027-07-11
Current total value of award: $1299972
Description: DHA STTR PHASE II PROPOSAL H2-0803, TITLED "DEVELOPMENT OF ANTIBODY TREATMENT OF MDR ESKAPE PATHOGEN, P. AERUGINOSA.", MEDICAL R&D CONTRACT.